Completed PHASE3 INTERVENTIONAL 2-arm NCT01535872

Study of Dehydroepiandrosterone Treatment for Poor Responders in In Vitro Fertilization Patients

Dehydroepiandrosterone Treatment for Poor Responders in IVF Patients: A Prospective Randomised Controlled Trial.

Sponsor: KK Women's and Children's Hospital

Conditions Infertility Poor Responder to IVF Treatment

Updated 7 times since 2017 Last updated: Aug 5, 2018 Started: Feb 29, 2012 Primary completion: Oct 31, 2014 Completion: Nov 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Infertility and Poor Responder to IVF Treatment, this trial is completed. The trial is conducted by KK Women's and Children's Hospital and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Sep 2018 — Jan 2021 [monthly]

Completed PHASE3

Status: Unknown Status → Completed
Jul 2018 — Sep 2018 [monthly]

Unknown Status PHASE3

Status: Active Not Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Jul 2018 [monthly]

Active Not Recruiting PHASE3
Jan 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE3

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

KK Women's and Children's Hospital

Data source: KK Women's and Children's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Singapore, Singapore